JP Patent

JP5975122B2 — ［（４−ヒドロキシ−２−オキソ−１，２，５，６−テトラヒドロ−３−ピリジニル）カルボニル］グリシン化合物の結晶形及びそれらの製造方法

Assigned to Taisho Pharmaceutical Co Ltd · Expires 2016-08-23 · 10y expired

What this patent protects

Patent listed against Jesduvroq.

Drugs covered by this patent

Patent Metadata

Patent number
JP5975122B2
Jurisdiction
JP
Classification
—
Expires
2016-08-23
Drug substance claim
No
Drug product claim
No
Assignee
Taisho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.